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Summary The monoclonal antibodies HMFG1 and HMFG2 identify antigens of the milk fat globule membrane which are also found on breast epithelial cells. Immunohistochemical staining was performed using both antibodies on formalin fixed, paraffin embedded sections of 93 breast carcinoma, 36 histologically benign lesions and 29 histologically normal breast tissue blocks. In both normal and benign breast disease the
staining was largely extracellular whilst in malignant tissue the staining was variable and often intracellular. Nine carcinomas did not stain with either antibody. The staining patterns of malignant tissues were graded
and no correlation was found between the grades and survival or indices of prognosis, (the oestrogen receptor
status, Bloom's grade and the presence dr absence of metastases to the axillary nodes.)
This study indicates that with the present methods available for grading staining patterns, although of
diagnostic value, these monoclonal antibodies are unlikely to assist in determining either the degree of tumour differentiation or prognosis in breast carcinoma.
The clinical application of antibodies in the
diagnosis and staging of human cancer has been
widely investigated. In breast cancer, oligoclonal
antisera to Epithelial Membrane Antigen (EMA)
(Heyderman et al., 1979) and anti human mam-
mary epithelial antigens (HME Ags) (Ceriani et al.,
1977) have been raised against the delipidated
milk fat globule membrane (MFGM), and have
been used in the early detection and diagnosis of
cancer. (Sloane & Ormerod, 1981; Sloane et al.,
1980, To et al., 1982; Dearnaley et al., 1981;
Ceriani et al., 1982).
A more widespread application could be achieved
by using monoclonal antibodies with a greater
specificity for one antigenic epitope. Recently, the
monoclonal antibodies HMFGI and HMFG2 have
been raised against the delipidated MFGM (Taylor-
Papadimitriou et al., 1981). These react against
different antigenic epitopes present on the same
molecule to which EMA antibodies are directed
(Ormerod et al., 1983). The immunohistochemical
staining patterns of both oligoclonal antibodies and
monoclonal antibodies to MFGM are extracellular in
the ducts and tubules of normal and benign breast
tissue and markedly heterogenous in malignant
breast tissue (Sloane & Ormerod, 1981; Arklie et
al., 1981).
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In the present study the heterogenous immuno-
histochemical staining patterns of HMFG1 and
HMFG2 in malignant breast tissue have been
characterised and graded. The grades have been
related to relapse-free survival and to prognostic
indicators presently in use; namely the nodal status
(Valagussa et al., 1978), Bloom's grade (Bloom &
Richardson, 1957) and oestrogen receptor status
(Cooke et al., 1979).
Materials and methods
Biopsy material from 130 women undergoing
surgery for breast disease was studied: From the
routine sections stained with haematoxylin and
eosin (H & E), 36 of the cases were diagnosed
histologically as benign and 93 as carcinoma. Of
the carcinoma cases, histologically normal tissue
surrounding the lesion was present in 29. Patients
with breast cancer were of two chronological
groups. Thirty-seven were treated in 1974 and 1975
and their subsequent survival until 1982 was
known. Fifty-six cases were treated in 1982 and
1983 and their oestrogen receptor status was
determined by Tenovus Laboratories (Cardiff)
using the dextran charcoal method (Cooke et al.,
1979). The presence of absence of metastatic spread
of the primary tumour to the axillary lymph node
was known for 89 of the patients with carcinoma.
The Bloom's grade for each case was determined
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independently from the routine H & E stained
sections.
The benign cases comprised the following:
fibroadenosis (16), fibroadenoma (11), lipoma (2),
papilloma (3), gynaecomastia (2), cyst (1), and duct
ectasia (1). The carcinomas were of the following
types: infiltrating ductal (67), lobular (5), mixed
ductal and lobular (3), medullary (3), infiltrating
comedocarcinoma (4), infiltrating cribriform (3),
mucoid (3), tunular (2), mixed medullary and
lobular (1) and carcinoid (2).
In each case the tissue was fixed in 10% neutral
buffered formol saline for -24-48h, taken through
alcohols and chloroform to paraffin wax on an
automatic processor, and embedded in paraffin
wax.
Staining ofsections
Sections (4pm) were cut from each block of tissue.
Endogenous peroxidase activity was inhibited using
0.5% H202 in methanol for 10min. The sections
were digested using 0.1% trypsin in 0.1% calcium
chloride solution at 37°C for 10min (Mepham et
al., 1979). In 10 cases control sections were not
digested in trypsin. The sections were stained using
an indirect immunoperoxidase assay (Burns, 1978).
The sections were incubated at room temperature
for 30min with HMFG1 or HMFG2 (gift from J.
Taylor Papadimitriou) as the primary antibody
and, after extensive washing, incubated for a
further 30min with peroxidase conjugated rabbit
anti mouse IgG (DAKO) as the second antibody. A
brown reaction product was developed using 3,3
diaminobenzidine tetrahydrochloride (DAB) (Sigma
Biochemicals).
For each sample negative controls using Tris
Buffered Saline (TBS) pH 7.6 in place of the
primary antibody were also included. In 20 cases 2
consecutive sections of the tissue were stained with
HMFG1 and HMFG2 on separate occasions to
determine the reproducibility of the staining
patterns.
Grading ofstaining patterns in malignant tissue
The staining patterns observed in malignant tissue
were graded according to the details in Table I. An
overall assessment of the relative intensity of
staining observed in the infiltrating regions of the
tumour was made at a magnification of x40,
taking into account the heterogeneity of staining. A
representative area of the section was then assessed
at a magnification of x 400 and the presence of
intracellular staining in 100 randomly observed cells
noted.
The 2 scores obtained for each tissue section were
then added such that a tissue with a completely
extracellular staining pattern scored 2 points, 1 for
the strong extracellular staining in tubules and 1
because 0-25% of the cells stained intracellularly. A
tissue section with strong intracellular staining
would score- 8 points, 4 because of the strong
intracellular staining diffusely distributed in the
cells and 4 because 76-100% of the cells stained
intracellularly.
The cases were then divided into 3 grades: those
not stained at all being grade 0, those scoring 2-5
points grade A and those scoring 6-8 points grade
B. To check the reproductibility of grading, all of
the 93 carcinoma cases were coded and then graded
on 2 separate occasions.
Statistics
The staining grades from the tissue sections were
correlated with Bloom's grade, Oestrogen receptor
status and involvement of axillary lymph nodes
using a Chi-squared test. Survival curves of the
different staining grades were plotted and analysed
using the SPSS "SURVIVAL" sub-programme (Nie
et al., 1981). Pairwise comparison of the curves was
Table I Scoring system for immunoperoxidase staining
Points
Staining observed scored
1. Relative intensity of staining strongest:
Extracellularly - in tubules I
Extracellularly - intercellularly and in intracytoplasmic
vacuoles 2
Intracellularly - localised towards periphery of cell 3
Intracellularly - diffusely distributed in the cytoplasm 4
2. Extent of intracellular staining:
0-25% 1
26-50% 2
51-75% 3
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performed using the Lee Desu statistic (Lee &
Desu, 1972).
Results
Controls
A comparison of the immunohistochemical staining
pattern in undigested and trypsin digested tissue
sections showed that trypsin digestion gave greater
staining intensity and reduced background staining
without affecting the distribution of the stain.
Of the 20 cases where 2 consecutive sections were
stained on separate occasions, the staining pattern
was reproducible, although the overall intensity of
staining in the sections often differed.
Normal and benign tissue
The staining pattern of histologically normal and
benign tissue with both HMFG1 and HMFG2 was
located on the luminal surface of cells lining and
secreted material within the ducts and tubules.
(Figure 1 & Figure 2). Staining of benign tissue was
generally greater than in normal tissue and varied
in extent and intensity both between histological
types of cases and between cases. No intracellular
staining was observed except in some benign cases
where weak intracellular staining was occasionally
observed in the apical region of cells lining ducts
and tubules which contained secretion.
Malignant tissue
Staining of malignant tissue varied from case to
case and within different areas of the same section.
HMFG1 and HMFG2 generally gave the same
staining patterns although the relative intensities of
the 2 antibodies varied (Table II). In 9 cases neither
antibody stained the tissue. In 5 cases where there
was extensive tubule formation, the staining pattern
was similar to that seen in normal and benign
tissue. All of the remaining 79 cases showed
intracellular staining to some extent with one or
both of the antibodies. In some cases the staining
was strongest extracellularly, either in tubules,
(Figure 3) or, where there were no tubules, in
intercellular spaces and intracytoplasmic vacuoles
(Figure 4). In other cases the staining was strongest
intracellularly, and was distributed either towards
the periphery of the cell (Figure 5) or diffusely in
the cytoplasm (Figure 6). Particularly strong
staining was observed in the strands of tumour
cells typical of lobular carcinoma and no staining
was present in the carcinoid tumours. There was no
other general association of the staining pattern
with the histological type of tumour.
Reproducibility ofthe staining grades
Eighty four percent of the sections were given the
same staining grade on 2 separate occasions. The
remaining 16% had been particularly difficult to
Figure 1 Immunohistochemical staining of histo- Figure 2 Immunohistochemical staining in a histo-
logically normal breast tissue with HMFG2. Extra- logically benign breast lesion, (fibroadenoma), with
cellular staining is apparent in the lumen of tubules. HMFG2. The pattern of extracellular staining is
(Indirect immunoperoxidase, x400). similar to normal tissue but shows greater intensity.
(Indirect immunoperoxidase, x 400).182 N. BERRY et al.
r
A.
4. * *-,;
,,!NX,..^;..,/t:Er:ERdi;.^UL ;; _.EasL *.s X~~~~~~~~~~~~~~~~~~~~~~~~~: .......
:.
a,
k: p:
L,i, ''m
AM
Figures 3-6 (3) Well differentiated infiltrating ductal carcinoma. Strong extracellular staining of HMFG2 is
present on the luminal surface of cells lining tubules. (Indirect immunoperoxidase, x400). (4) Infiltrating
ductal carcinoma. Immunoperoxidase staining shows HMFG2 antigen extracellularly, both between the cells
(A) and in intracytoplasmic vacuoles (B). (Indirect immunoperoxidase, x400). (5) Infiltrating ductal
carcinoma. Illustrates granular cytoplasmic staining of HMFG2 antigen which is more pronounced at the cell
membrane. (Indirect immunoperoxidase, x 400). (6) Infiltrating ductal carcinoma. Diffuse intracellular
staining of HMFG2 antigen is present. (Indirect immunoperoxidase, x 400).
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Table II Table of immunohistochemical staining patterns of HMFG1 and HMFG2 in
breast cancer
Tissue histology Description ofimmunohistochemical staining with HMFGJ and HMFG2
Normal Extracellular - staining on the luminal surface of cells lining and
secretions within the ducts and tubules.
No intracellular staining.
Benign Extracellular - As above, but occasionally with weak intracellular
staining in the apical region of cells lining ducts and
tubules which contained secretion.
Malignant 5/93 Extracellular - As normal above
9/93 No staining with either HMFG1 or HMFG2
79/93 Intracellular - marked heterogeneity of both the extent of
intracellular staining and the relative intensity of staining from
stronger extracellularly to stronger intracellularly.
grade because of the variability of staining
throughout the section.
Relation ofthe staining grades to bloom's grade
Twelve of the 93 carcinomas were Bloom's grade 1.
In 9 of these the staining pattern was grade A with
both HMFG1 and HMFG2. One of the 12 cases
did not stain with either antibody and in 1 the
staining pattern was Grade A with HMFG2 only.
Fifteen cases were Bloom's grade 3 and 66 were
Bloom's grade 2 (Table III). No significant
association was found between the staining grades
A, B or 0 and Bloom's grade 2 or 3 (Chi-squared
test). The lack of correlation was obtained in
sections stained with either HMFG1 or HMFG2.
(P=7.23; P=6.77).
Table III Relationship of the staining
grades obtained with HMFG1 and HMFG2
to Bloom's Grade in 93 breast carcinomas
Bloom's Grade
HMFGI HMFG2
Staining
grade 1 2 3 1 2 3
A 9 26 7 10 30 6
B 2 30 4 1 28 7
0 1 10 4 1 8 2
Relation of the staining grades to oestrogen receptor
status
Twenty-four of the 56 cases from 1982-3 were
oestrogen receptor positive and 32 were oestrogen
receptor negative. There was no significant
association between the staining grade A, B or 0
and the oestrogen receptor status of the tumours
(Chi-squared test) (Figure 7). The lack of
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Figure 7 Relation of the staining grades to oestrogen
receptor status. (Ol)=E.R.+; (M)=E.R.-.
correlation was present in sections stained with
either HMFG1 or HMFG2. (P= 1.93, P=2.04).
Relation of the staining grades to the presence of
nodal metastases
Thirty-five of the 89 cases were reported as having
metastases in the axillary nodes and 55 had no
rodal metastases. There is no significant association
between the staining grade A, B or 0 and the
presence or absence of nodal metastases (Chi-
squared test) (Figure 8). The correlation was
insignificant in sections stained with either HMFG1
or HMFG2 (P= 3.09; P=0.92).
Life table analysis comparing the staining grades
Survival curves of patients from 1974-5 with
staining grade A, B and 0 are illustrated in Figure
9. Although there appeared to be some differences
between the curves, particularly with HMFG2,
statistical analysis of the 3 curves showed that there
was no significant difference in the survival of each
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Figure 8 Relation of staining grades to the presence
of nodal metastases. (L)=Node +; (-) =Node-.
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Figure 9 Life table analysis comparing the staining
grades. (L1)=Grade 0; (A)= Grade A; (-)= Grade B.
staining group in sections stained with either
HMFG1 or HMFG2 (P=0.79; P=0.18).
Discussion
The immunohistochemical staining patterns of the
monoclonal antibodies HMFG1 and HMFG2 in
breast tissue have been described previously (Arklie
et al., 1981). The patterns observed in this study are
similar, that is, extracellular in the ducts and
tubules of normal and benign tissue and variable in
malignant tissue.
The heterogeneity of staining in malignant breast
tissue was apparent both in the extent of
intracellular staining and in the relative intensity of
staining. In some cases extracellular staining was
observed both in tubules and between cells.
Staining of the intracytoplasmic vacuoles was also
considered extracellular, as electron microscopy has
shown that the surface of the inner membrane of
the vacuole has features typical of the exterior
surface of the cell membranes (Battifora, 1975). In
other cases staining was stronger intracellularly
distributed either towards the periphery of the cell
or diffusely throughout the cytoplasm. Nine percent
of the tumours did not stain with either HMFGI
or HMFG2 and a further 2% did not stain with
one of the antibodies. Wilkinson et al. (1984) have
noted a similar percentage of negatively staining
tumours.
Caution should be exerted when comparing
immunohistochemical staining characteristics
between studies, since differences in tissue
preparation and staining technique may be of
importance (Brandtzaeg & Rognum, 1982).
The change in the immunohistochemical staining
pattern from extracellular in normal and benign
breast tissue to mixed with varying amounts of
intracellular positivity in malignant breast tissue has
been observed using other antibodies (Sloane &
Ormerod, 1981; Foster et al., 1982) and lectins
(Franklin, 1983).
The staining grades were designed to reflect the
immunohistochemical staining patterns observed,
whilst being in a form which could be related to
indices of prognosis and to survival. Since the
staining pattern in normal, benign and structurally
differentiated tumours (those with extensive tubule
formation) was extracellular, and became more
intracellular as structural differentiation was lost,
the grading system took into account the relative
intensity of extracellular and intracellular staining
and also the number of cells with intracellular
staining. The 20 control sections where 2
consecutive sections were stained on separate
occasions showed the same staining pattern on both
sections but the overall intensity of stain
throughout the section varied. Little emphasis,
therefore, was placed on the overall intensity of the
stain. Heterogeneity was observed between different
areas of a tissue section and was a limitation of the
grading system, for one area of tissue with a less
predominant staining pattern, and therefore not
graded, might influence the survival of the patient
unnoticed. This heterogeneity also made grading
difficult in many cases, but when the sections were
graded on 2 separate occasions 84% reproducibility
was obtained. This method of grading the stains
contrasts with that used in another study relating
the immunohistochemical staining of HMFG1 to
survival and to indices of prognosis (Wilkinson et
al., 1984), where the grading was based on the
uniformity, extent and the overall intensity of the
stain.
There was no significant correlation when the
staining grades were related to indices of prognosis
and relapse-free survival. A significant correlation
might have been expected when relating the staining
grades to Bloom's grade since tumours with
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extensive tubule formation had an extracellular
staining pattern. Three measures of differentiation
contribute to Bloom's Grade of which tubule
formation is one. The other 2 factors might
combine to put a tumour with much tubule
formation into Bloom's grade 2. Since extracellular
staining was also recognised in intercellular spaces
and intracytoplasmic vacuoles as well as in tubules,
significant correlation with Bloom's grade is
unlikely.
There was no association of the staining grades
with oestrogen receptor status. In addition no
correlation of the staining grades with involvement
of axillary lymph nodes was observed. There was,
however, a trend, in that a Grade A staining
pattern with both HMFG1 and HMFG2 was more
frequently seen in patients without lymph node
involvement.
For HMFG1 and HMFG2 to be useful in
determining the prognosis of breast cancer patients,
the different staining patterns observed should be
either closely correlated to existing prognostic
indicators or be clearly related to survival, even in a
relatively small series of cases. Relating the relapse-
free survival of 34 patients to the staining grade,
although there appeared to be some difference
between the survival curves of the 3 staining grades,
statistical comparison of the curves showed that
they were not significantly different when either
HMFG1 or HMFG2 was used. The antibodies are
therefore of little use in routine diagnosis. Similar
results were obtained by Wilkinson et al. (1984)
where there was no significant association of the
staining patterns observed to indices of prognosis
such as Bloom's grade, the presence of metastases
in the axillary nodes and the oestrogen receptor
status. However, these authors identified a group of
patients whose tumours did not stain with HMFG1
and who had a particularly poor prognosis. High
levels of extracellular staining were considered
indicators of a good prognosis. Although the
immunoperoxidase staining technique was different
in some respects to the one used in this study, a
comparison of the staining patterns observed using
the 2 techniques in 10 cases showed agreement. The
different results must therefore be either due to the
different method of grading used or, in the case of
those patients with negatively stained tumours, the
small number of cases.
The results of this study show that with present
methods available for grading staining patterns the
immunohistochemical staining patterns of HMFG1
and HMFG2 in malignant breast tissue do not help
in determining the overall prognosis in an
indivudual patient.
We acknowledge the work of the technical staff in the
Pathology Dept., Faculty of Medicine, University of
Southampton in preparing the illustrations.
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